Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
KRYS
$332.56
-0.75%
KRYS
· Krystal Biotech, Inc.
$332.56
-2.50 (-0.75%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$10.24B
Shares
29.60M
Volume · Sep 30
268.27K
Avg daily vol (3M)
373.58K
All earnings calls
Earnings call · FY2024 Q2
Krystal Biotech, Inc. (KRYS) Q2 2024 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$70.28M
Diluted EPS
$0.53
Net income
$15.57M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 5, 2024.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Non-GAAP combined Research and Development and Selling, General
Initiated
year ending December 31, 2024
|
$150M – $175M | Non-GAAP |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 5, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2024 · complete as-filed document